Today's Research Daily features new research reports on 16 major stocks, including Toyota Motor Corp. (TM), AstraZeneca PLC ...

AstraZeneca AZN stock has risen 13.6% in the past six months, outperforming an increase of 7.1% for the industry. AstraZeneca ...

The drug and biotech sector has outperformed the broader equity market this year, backed by the launch of promising new ...

Lytham Partners Fall 2024 Investor Conference Date and Time: Tuesday, October 1, 2024 at 4:15 p.m. ET Location: Virtual Format: Fireside Chat and 1x1 Meetings Registration link for the event: ...

German healthcare company Fresenius Group announced this week the appointment of Nick Stone as its new head of IR, effective ...

Harvey Jones is in bargain-hunting mode and wondering if these two FTSE 100 shares could make exciting purchases after falling sharply in the last month.

Loss for the half-year reduced by 21% at £7.7 million, or 2.89 pence per share (H1 2023: loss £9.8 million, or 3.77 pence per share) Fundraise completed in June 2024 raising £9.3 million (gross) to ...

Stock Market LIVE Updates | Domestic stocks reached a new milestone on Tuesday, with the Sensex surpassing 85,000 and the ...

First he took a sip of tea to gather his composure. Then Chinese central banker Pan Gongsheng unleashed one of the country’s ...

Astrazeneca Pharma India Ltd registered volume of 10.98 lakh shares by 14:14 IST on NSE, a 166.41 fold spurt over two-week average daily volume of 6599 shares ...

This surge came after the company announced approval to import and distribute Durvalumab (Imfinzi) infusion in two dosages.